ArticleRespirology case reports2026
Prospective Case Series to Determine the Feasibility, Diagnostic Yield and Safety of Performing EBUS Guided Trans-Bronchial Mediastinal Cryobiopsy (EBUS-TBMC) of Lymph Nodes Using 1.1 mm Cryoprobe Through a Working Channel of Linear EBUS Bronchoscope Versus Conventional En-Bloc Cryobiopsy.
Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
EBUS-guided trans-bronchial mediastinal cryobiopsy (EBUS-TBMC) improves diagnostic yield over EBUS-TBNA but conventionally requires en-bloc removal of bronchoscope and frozen specimen, risking loss of airway control and procedural inefficiency. Retrieval of cryobiopsy specimens through-working channel (TWC) may address these limitations, but its feasibility and diagnostic adequacy are uncertain. Prospective evaluation was completed of 13 patients undergoing EBUS-TBMC at a single centre (August 2025 to January 2026). A 1.1 mm Erbe cryoprobe was advanced through an echobronchoscope with a 2.2 mm working channel (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.